138
Views
0
CrossRef citations to date
0
Altmetric
Research Article

O-Know Opioid Knowledge Test: Development and Psychometric Testing in a Community Setting

ORCID Icon, &
Pages 135-145 | Received 28 Mar 2022, Accepted 23 Sep 2022, Published online: 21 Nov 2022

References

  • Adams, J. M., and N. D. Volkow. 2020. Ethical imperatives to overcome stigma against people with substance use disorders. AMA Journal of Ethics 22 (1):E702–E708. doi:10.1001/amajethics.2020.702.
  • American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders – 5. (5th (Arlington, VA: American Psychiatric Association) ed).
  • Armstrong, J. S. 1967. Derivation of theory by means of factor analysis or Tom Swift and his electric factor analysis machine. American Statistician 21 (5):17–21. doi:10.2307/2682655.
  • Brown, T. A. 2015. Confirmatory factory analysis for applied research. 2nd ed. New York, NY: The Guilford Press.
  • Buchman, D. Z., J. Illes, and P. B. Reiner. 2011. The paradox of addiction neuroscience. Neuroethics 4 (2):65–77. doi:10.1007/s12152-010-9079-z.
  • Bulck, L. V., M. Wampers, and P. Moons. 2022. Research Electronic Data Capture (REDCap): Tackling data collection, management, storage, and privacy challenges. European Journal of Cardiovascular Nursing 21 (1):85–91. doi:10.1093/eurjcn/zvab104.
  • Cattell, R. B. 1966. The scree test for the number of factors. Multivariate Behavioral Research 1 (2):245–76. doi:10.1207/s15327906mbr0102_10.
  • Center for Behavioral Health Statistics and Quality. 2016. 2015 national survey on drug use and health: detailed tables. Rockville, MD: Substance Abuse and Mental Health Services Administration.
  • Center for Substance Abuse Treatment. (2005). Medication assisted treatment for opioid addiction in opioid treatment programs. Treatment Improvement Protocol (TIP) series 43. DHHS Publication No. (SMA) 06-4214. Rockville, MD: Substance Abuse and Mental Health Services Administration
  • Centers for Disease Control and Prevention (2021, November 17). Drug overdose deaths in the U.S. Top 100,000 Annually. https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2021/20211117.htm
  • Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum.
  • Cooper, S., and S. Nielsen. 2017. Stigma and social support in pharmaceutical opioid treatment populations: A scoping review. International Journal of Mental Health and Addiction 15 (2):452–69. doi:10.1007/s11469-016-9719-6.
  • Cortina, J. M. 1993. What is coefficient alpha? An examination of theory and applications. Journal of Applied Psychology 78 (1):98–104. doi:10.1037/0021-9010.78.1.98.
  • Dart, R. C., J. L. Iwanicki, J. C. Black, H. A. Olsen, and S. G. Severtson. 2021. Measuring prescription opioid misuse and its consequences. British Journal of Clinical Pharmacology 87 (4):1647–53. doi:10.1111/bcp.14791.
  • Dunn, K. E., F. S. Barrett, C. Yepez-Laubach, A. C. Meyer, B. J. Hruska, S. C. Sigmon, M. Fingerhood, and G. E. Bigelow. 2016. Brief Opioid Overdose Knowledge (BOOK): A questionnaire to assess overdose knowledge in individuals who use illicit or prescribed opioids. Journal of Addiction Medicine 10 (5):314–23. doi:10.1097/ADM.0000000000000235.
  • Florence, C. S., C. Zhou, F. Luo, and L. Xu. 2016. The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013. Medical Care 54 (10):901–06. doi:10.1097/MLR.0000000000000625.
  • Fraser, S., K. Pienaar, E. Dilkes-Frayne, D. Moore, R. Kokanovic, C. Treloar, and A. Dunlop. 2017. Addiction stigma and the biopolitics of liberal modernity: A qualitative analysis. International Journal of Drug Policy 44:192–201. doi:10.1016/j.drugpo.2017.02.005.
  • Furr-Holden, D., A. J. Milam, L. Wang, and R. Sadler. 2021. African Americans now outpace whites in opioid‐involved overdose deaths: A comparison of temporal trends from 1999 to 2018. Addiction 116 (3):677–83. doi:10.1111/add.15233.
  • Global Commission on Drug Policy. (2021). The world drug perception problem: Countering prejudices about people who use drugs. http://www.globalcommissionondrugs.org/reports/changing-perceptions
  • Gonsalves, G. S., and F. W. Crawford. 2018. Dynamics of the HIV outbreak and response in Scott County, IN, USA, 2011-15: A modelling study. The Lancet. HIV 5 (10):e569–e577. doi:10.1016/S2352-3018(18)30176-0.
  • Gorsuch, R. L. 1983. Factor Analysis. 2nd ed. Hillsdale, New Jersey: Erlbaum.
  • Grieve, R., K. Witteveen, and G. A. Tolan. 2014. Social media as a tool for data collection: Examining equivalence of socially value-laden constructs. Current Psychology: A Journal for Diverse Perspectives on Diverse Psychological Issues 33 (4):532–44. doi:10.1007/s12144-014-9227-4.
  • Guttman, L. 1954. Some necessary conditions for common-factor analysis. Psychometrika 19 (2):149–61. doi:10.1007/BF02289162.
  • Hamra, M., M. W. Ross, M. Orrs, and A. D’Agostino. 2006. Relationship between expressed HIV/AIDS-related stigma and HIV-beliefs/knowledge and behaviour in families of HIV infected children in Kenya. Tropical Medicine & International Health: TM & IH 11 (4):513–27. doi:10.1111/j.1365-3156.2006.01583.x.
  • Horn, J. L. 1965. A rationale and test for the number of factors in factor analysis. Psychometrika 30 (2):179–85. doi:10.1007/BF02289447.
  • Horwitz, A. V. 2002. Creating Mental Illness. Chicago, IL: The University of Chicago Press.
  • Jones, C. M., E. B. Einstein, and W. M. Compton. 2018. Changes in synthetic opioid involvement in drug overdose deaths in the United States, 2010-2016. JAMA 319 (17):1819–21. doi:10.1001/jama.2018.2844.
  • Lanzillotta-Rangeley, J., T. A. Zeller, T. Beachler, A. H. Litwin, A. Clark, and J. Stem. 2021. The impact of the disease model of substance use disorder on evidence based practice adoption and stigmatizing attitudes: A comparative analysis. Pain Management Nursing: Official Journal of the American Society of Pain Management Nurses 22 (5):616–22. doi:10.1016/j.pmn.2021.03.004.
  • Lim, S., and S. Jahng. 2019. Determining the number of factors using parallel analysis and its recent variants. Psychological Methods 24 (4):452–67. doi:10.1037/met0000230.
  • Livingston, J. D., T. Milne, M. L. Fang, and E. Amari. 2012. The effectiveness of interventions for reducing stigma related to substance use disorders: A systematic review. Addiction 107 (1):39–50. doi:10.1111/j.1360-0443.2011.03601.x.
  • Lynn, M. 1986. Determination and quantification of content validity index. Nursing Research 35 (6):382–86. doi:10.1097/00006199-198611000-00017.
  • Meurk, C., A. Carter, B. Partridge, J. Lucke, and W. Hall. 2014. How is acceptance of the brain disease model of addiction related to Australians’ attitudes towards addicted individuals and treatments for addiction? BMC Psychiatry 14 (1):1–17. doi:10.1186/s12888-014-0373-x.
  • Mokkink, L. B., C. B. Terwee, D. L. Knol, P. W. Stratford, J. Alonso, D. L. Patrick, L. M. Bouter, and H. C. W. de Vet. 2010. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: A clarification of its content. BMC Medical Research Methodology 10 (1):22–29. doi:10.1186/1471-2288-10-22.
  • Moore, M. D., S. Ali, D. Burnich-Line, W. Gonzales, and M. V. Stanton. 2020. Stigma, opioids, and public health messaging: The need to disentangle behavior from identity. American Journal of Public Health 110 (6):807–10. doi:10.2105/AJPH.2020.305628.
  • Murphy, S. M., D. Polsky, J. D. Lee, P. D. Friedmann, T. W. Kinlock, E. V. Nunes, R. J. Bonnie, M. Gordon, D. T. Chen, T. Y. Boney, et al. 2017. Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder. Addiction 112 (8):1440–50. doi:10.1111/add.13807.
  • Next Level Recovery Indiana. (2022). Know the facts about substance use disorder in Indiana. https://www.in.gov/recovery/know-the-facts/
  • Nunnally, J. C., and I. H. Bernstein. 1994. Psychometric theory. 3rd ed. New York: McGraw-Hill.
  • Palamar, J. J., M. V. Kiang, and P. N. Halkitis. 2011. Development and psychometric evaluation of scales that assess stigma associated with illicit drug users. Substance Use & Misuse 46 (12):1457–67. doi:10.3109/10826084.2011.596606.
  • Pasman, E. 2022. Reducing stigma toward medication for opioid use disorder through social work education, research, and practice. Journal of Social Work Practice in the Addictions 22 (1):86–92. doi:10.1080/1533256X.2022.2016339.
  • Quinn, K., C. Fong, H. Guarino, and P. Mateu-Gelabert. 2019. Development, validation, and potential applications of the hepatitis C virus injection-risk knowledge scale (HCV-IRKS) among young opioid users in New York City. Drug and Alcohol Dependence 194:453–59. doi:10.1016/j.drugalcdep.2018.11.010.
  • Rummans, T. A., M. C. Burton, and N. L. Dawson. 2018. How good intentions contributed to bad outcomes: The opioid crisis. Mayo Clinic Proceedings 93 (3):344–50. doi:10.1016/j.mayocp.2017.12.020.
  • Rüsch, N., M. C. Angermeyer, and P. W. Corrigan. 2005. Mental illness stigma: Concepts, consequences, and initiatives to reduce stigma. European Psychiatry 20 (8):529–39. doi:10.1016/j.eurpsy.2005.04.004.
  • Schmitt, N. 1996. Uses and abuses of coefficient alpha. Psychological Assessment 8 (4):350–53. doi:10.1037/1040-3590.8.4.350.
  • Shidlansik, L., M. Adelson, and E. Peles. 2017. Knowledge and stigma regarding methadone maintenance treatment among personnel of methadone maintenance treatment and non-methadone maintenance treatment addiction facilities in Israel. Journal of Addictive Diseases 36 (1):30–37. doi:10.1080/10550887.2016.1235404.
  • Taber, K. S. 2018. The Use of Cronbach’s alpha when developing and reporting research instruments in science education. Research in Science Education 48 (6):1273–96. doi:10.1007/s11165-016-9602-2.
  • Townsend, T., D. Kline, A. Rivera-Aguirre, A. M. Bunting, P. M. Mauro, B. D. L. Marshall, S. S. Martins, and M. Cerdá. 2022. Racial/ethnic and geographic trends in combined stimulant/opioid overdoses, 2007-2019. American Journal of Epidemiology 191 (4):599–612. doi:10.1093/aje/kwab290.
  • Trujols, J. 2015. The brain disease model of addiction: Challenging or reinforcing stigma? The Lancet. Psychiatry 2 (4):292. doi:10.1016/S2215-0366(15)00050-4.
  • Volkow, N. D., E. B. Jones, E. B. Einstein, and E. M. Wargo. 2019. Prevention and treatment of opioid misuse and addiction: A review. JAMA Psychiatry 76 (2):208–16. doi:10.1001/jamapsychiatry.2018.3126.
  • Wallace, W. 1971. The logic of science in sociology. Chicago, IL: Aldine de Gruyter.
  • Wiens, T. K., and L. J. Walker. 2015. The chronic disease concept of addiction: Helpful or harmful? Addiction Research & Theory 23 (4):309–21. doi:10.3109/16066359.2014.987760.
  • Williams, A. V., J. Strang, and J. Marsden. 2013. Development of Opioid Overdose Knowledge (OOKS) and Attitudes (OOAS) Scales for take-home naloxone training evaluation. Drug and Alcohol Dependence 132 (1–2):383–86. doi:10.1016/j.drugalcdep.2013.02.007.
  • Yeni, K., Z. Tulek, O. F. Simsek, and N. Bebek. 2018. Relationships between knowledge, attitudes, stigma, anxiety and depression, and quality of life in epilepsy: A structural equation modeling. Epilepsy & Behavior: E&B 85:212–17. doi:10.1016/j.yebeh.2018.06.019.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.